1.F.1.1.1 The SNARE fusion complex, fusing neurotransmitter vesicles with the presynaptic membrane. Ca2+ acts on the synaptic vesicle synaptotagmin1 (synaptotagmin I; SytI, Syt1, SSVP65, SYT) to trigger rapid exocytosis (Chapman, 2008). Syt1 is a major Ca2+ sensor for fast neurotransmitter release. It contains tandem
Ca2+-binding C2 domains (C2AB), a single transmembrane α-helix and a highly charged 60-residue-
long linker in between. The
linker region of Syt1 is essential for its two signature functions: Ca2+-independent vesicle docking
and Ca2+-dependent fusion pore opening. The linker contains the basic-amino acid-rich N-terminal
region and the acidic amino acid-rich C-terminal region (Lai et al. 2013). The intrinsically disordered region
between Syt I's transmembrane helix and the first C2 domain interats with vesicular lipids and modulates Ca2+ binding to C2 (Fealey et al. 2016). t-SNARE and v-SNARE interact in their C-terminal TMSs to promote pore opening (Wu et al. 2016). Both sides of a trans-SNARE complex can drive pore opening suggesting an indentation model in which multiple SNARE C-termini cooperate in opening the
fusion pore by locally deforming the inner leaflets (D'Agostino et al. 2016). The TMSs of SNARE proteins regulate the fusion process (Wu et al. 2017). The cysteine-rich domain of SNAP-23 regulates its membrane association and exocytosis from mast cells (Agarwal et al. 2019). Snc1 is trafficked between the endosomal system and the Golgi apparatus via multiple pathways, providing evidence for protein quality control surveillance of a SNARE protein in the endo-vacuolar system (Ma and Burd 2019). MemDis is a novel prediction method, utilizing a convolutional neural network and long short-term memory networks for predicting disordered regions in transmembrane proteins (Dobson and Tusnády 2021). Curcuminoids (bisdemethoxycurcumin and curcumin) modulate the release of neurotransmitters during exocytosis (Li et al. 2016). Oxidative stress-induced inhibition of VAMP8 trafficking to lysosomes is
associated with the development of neurodegenerative diseases due to
blocked autophagosome-lysosome fusion (Ohnishi et al. 2022). Calcium (Ca2+) plays a critical role in triggering all three
primary modes of neurotransmitter release (synchronous, asynchronous,
and spontaneous). Synaptotagmin1, a protein with two C2 domains, is the
first isoform of the synaptotagmin family that was identified and
demonstrated as the primary Ca2+ sensor for synchronous
neurotransmitter release (Zhou 2023). Other isoforms of the synaptotagmin family as
well as other C2 proteins such as members of the double C2 domain protein family
were found to act as Ca2+ sensors for different modes of
neurotransmitter release. A new model, release-of-inhibition, for the initiation of Ca2+-triggered synchronous neurotransmitter release has been proposed. Synaptotagmin1 binds Ca2+ via its two C2 domains and relieves a primed pre-fusion machinery. Before Ca2+ triggering, synaptotagmin1 interacts Ca2+ independently with partially zippered SNARE complexes, the plasma
membrane, phospholipids, and other components to form a primed
pre-fusion state that is ready for fast release. However, membrane
fusion is inhibited until the arrival of Ca2+ reorients the Ca2+-binding
loops of the C2 domain to perturb the lipid bilayers, help bridge the
membranes, and/or induce membrane curvatures, which serves as a power
stroke to activate fusion (Zhou 2023). Synaptobrevin2 (Syb2) monomers and dimers differentially engage in regulating the trans-SNARE assembly during membrane fusion. The differential recruitment of two syb2 structures at the membrane fusion site has consequences in regulating individual nascent fusion pore properties. A few syb2 transmembrane domain residues control monomer/dimer conversion. Thus, syb2 monomers and dimers are differentially recruited at the release sites for regulating membrane fusion events (Patil et al. 2024).
|
Accession Number: | P63027 |
Protein Name: | Synaptobrevin-2 aka VAMP-2 |
Length: | 116 |
Molecular Weight: | 12663.00 |
Species: | Homo sapiens (Human) [9606] |
Number of TMSs: | 1 |
Location1 / Topology2 / Orientation3: |
Cytoplasmic vesicle1 / Single-pass type IV membrane protein2 |
Substrate |
|
---|
RefSeq: |
NP_055047.2
|
Entrez Gene ID: |
6844
|
Pfam: |
PF00957
|
OMIM: |
185881 gene
|
|
[1] “Structures and chromosomal localizations of two human genes encoding synaptobrevins 1 and 2.” Archer B.T. III et.al. 1976629
[2] “Complete sequencing and characterization of 21,243 full-length human cDNAs.” Ota T. et.al. 14702039
[3] “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).” The MGC Project Team et.al. 15489334
[4] “Insulin-responsive tissues contain the core complex protein SNAP-25 (synaptosomal-associated protein 25) A and B isoforms in addition to syntaxin 4 and synaptobrevins 1 and 2.” Jagadish M.N. et.al. 8760387
[5] “Transport route for synaptobrevin via a novel pathway of insertion into the endoplasmic reticulum membrane.” Kutay U. et.al. 7835332
[6] “Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 A resolution.” Hanson M.A. et.al. 10932255
|
|
1: MSATAATAPP AAPAGEGGPP APPPNLTSNR RLQQTQAQVD EVVDIMRVNV DKVLERDQKL
61: SELDDRADAL QAGASQFETS AAKLKRKYWW KNLKMMIILG VICAIILIII IVYFST